M
Mankind Pharma Ltd
Pharmaceuticals
LARGECAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 55.85 | 51.53 |
| PB Ratio | 11.16 | 6.56 |
| Dividend Yield | — | 0.52% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
M
Mankind Pharma Ltd
Mankind Pharma Ltd develops and markets a wide range of pharmaceutical formulations across various therapeutic areas, including anti-infectives and cardiovascular products.
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions